跳至主要内容

博文

目前显示的是标签为“上市”的博文

Camrelizumab may be approved as 3rd line treatment fot r/r cHL in the coming days.

In 2019.5.5, the NDA left CDE to NMPA for the final approval. Finally it will be approved in the coming days soon.